LifeVantage (LFVN) Projected to Post Quarterly Earnings on Tuesday

LifeVantage (NASDAQ:LFVNGet Free Report) is expected to announce its earnings results before the market opens on Tuesday, January 28th. Analysts expect the company to announce earnings of $0.14 per share and revenue of $51,900.00 billion for the quarter. LifeVantage has set its FY 2025 guidance at 0.700-0.800 EPS.Individual interested in listening to the company’s earnings conference call can do so using this link.

LifeVantage (NASDAQ:LFVNGet Free Report) last released its quarterly earnings results on Tuesday, October 29th. The company reported $0.15 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.15. LifeVantage had a return on equity of 29.24% and a net margin of 2.11%. The business had revenue of $47.21 million for the quarter.

LifeVantage Price Performance

NASDAQ LFVN opened at $24.24 on Monday. The business has a 50 day moving average price of $17.80 and a 200 day moving average price of $12.82. The company has a market capitalization of $303.48 million, a P/E ratio of 75.75 and a beta of 0.82. LifeVantage has a 1-year low of $5.22 and a 1-year high of $27.38.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on LFVN shares. Lake Street Capital assumed coverage on LifeVantage in a research report on Thursday, December 19th. They issued a “buy” rating and a $26.00 price target for the company. Craig Hallum started coverage on shares of LifeVantage in a report on Tuesday, January 14th. They set a “buy” rating and a $35.00 target price for the company.

View Our Latest Analysis on LifeVantage

LifeVantage Company Profile

(Get Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

See Also

Earnings History for LifeVantage (NASDAQ:LFVN)

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.